AIM ImmunoTech Receives Statistically Significant Positive Survival Results in Pancreatic Cancer from Erasmus University Medical Center, Rotterdam, Netherlands
Median survival approximately two-fold higher in Ampligen arm compared to historical controls; AIM to seek…